| Year |
Title |
Altmetric |
| 2019
|
Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure.
Circulation Research.
124:161-169.
2019
|
|
| 2019
|
Cytoplasmic PARP-1 promotes pancreatic cancer tumorigenesis and resistance.
International Journal of Cancer.
2019
|
|
| 2018
|
Defining the epigenetic status of blood cells using a cyanine-based fluorescent probe for PRMT1..
Blood Adv.
2:2829-2836.
2018
|
|
| 2018
|
AKT-independent activation of p38 MAP kinase promotes vascular calcification.
Redox Biology.
16:97-103.
2018
|
|
| 2017
|
Dietary potassium regulates vascular calcification and arterial stiffness..
JCI insight.
2.
2017
|
|
| 2017
|
The interplay between calmodulin and membrane interactions with the pleckstrin homology domain of akt.
Journal of Biological Chemistry.
292:251-263.
2017
|
|
| 2017
|
The long non-coding RNA HOTAIR enhances pancreatic cancer resistance to TNF-related apoptosis-inducing ligand.
Journal of Biological Chemistry.
292:10390-10397.
2017
|
|
| 2016
|
Redox signaling in cardiovascular pathophysiology: A focus on hydrogen peroxide and vascular smooth muscle cells.
Redox Biology.
9:244-253.
2016
|
|
| 2016
|
The AS-RBM15 lncRNA enhances RBM15 protein translation during megakaryocyte differentiation.
EMBO Reports.
17:887-900.
2016
|
|
| 2016
|
Identification of initial leads directed at the calmodulin-binding region on the Src-SH2 domain that exhibit anti-proliferation activity against pancreatic cancer.
Bioorganic and Medicinal Chemistry Letters.
26:1237-1244.
2016
|
|
| 2016
|
TLR4 regulates Pulmonary vascular homeostasis and remodeling via redox signaling.
Frontiers in Bioscience.
21:397-409.
2016
|
|
| 2015
|
Molecular Mechanisms of Vascular Calcification in Chronic Kidney Disease: The Link between Bone and the Vasculature.
Current Osteoporosis Reports.
13:206-215.
2015
|
|
| 2015
|
Inhibition of FOXO1/3 promotes vascular calcification.
Arteriosclerosis, Thrombosis, and Vascular Biology.
35:175-183.
2015
|
|
| 2015
|
Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.
Oncotarget.
6:25308-25319.
2015
|
|
| 2014
|
Activation of AKT by O-linked N-Acetylglucosamine induces vascular calcification in diabetes mellitus.
Circulation Research.
114:1094-1102.
2014
|
|
| 2013
|
PARP-1 regulates resistance of pancreatic cancer to trail therapy.
Clinical Cancer Research.
19:4750-4759.
2013
|
|
| 2013
|
Structural and biophysical characterization of the interactions between the death domain of fas receptor and calmodulin.
Journal of Biological Chemistry.
288:21898-21908.
2013
|
|
| 2012
|
Vascular smooth muscle cell smad4 gene is important for mouse vascular development.
Arteriosclerosis, Thrombosis, and Vascular Biology.
32:2171-2177.
2012
|
|
| 2012
|
Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification.
Circulation Research.
111:543-552.
2012
|
|
| 2012
|
Serum response factor regulates bone formation via IGF-1 and Runx2 signals.
Journal of Bone and Mineral Research.
27:1659-1668.
2012
|
|
| 2012
|
Reduced CaM/FLIP binding by a single point mutation in c-FLIP L modulates Fas-mediated apoptosis and decreases tumorigenesis.
Laboratory Investigation.
92:82-90.
2012
|
|
| 2011
|
Trifluoperazine regulation of calmodulin binding to Fas: A computational study.
Proteins.
79:2543-2556.
2011
|
|
| 2011
|
Calmodulin mediates Fas-induced FADD-independent survival signaling in pancreatic cancer cells via activation of Src-Extracellular Signal-regulated Kinase (ERK).
Journal of Biological Chemistry.
286:24776-24784.
2011
|
|
| 2011
|
Runx2-upregulated receptor activator of nuclear factor κb ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages.
Arteriosclerosis, Thrombosis, and Vascular Biology.
31:1387-1396.
2011
|
|
| 2011
|
Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis.
Laboratory Investigation.
91:896-904.
2011
|
|
| 2011
|
Mechanisms and consequences of salt sensitivity and dietary salt intake.
Current Opinion in Nephrology and Hypertension.
20:37-43.
2011
|
|
| 2010
|
RANKL up-regulates brain-type creatine kinase via poly(ADP-ribose) polymerase-1 during osteoclastogenesis.
Journal of Biological Chemistry.
285:36315-36321.
2010
|
|
| 2009
|
Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4.
Laboratory Investigation.
89:1221-1228.
2009
|
|
| 2009
|
Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: Role of calmodulin.
Clinical Cancer Research.
15:1288-1296.
2009
|
|
| 2008
|
A conserved domain of previously unknown function in Gap1 mediates protein-protein interaction and is required for biogenesis of a serine-rich streptococcal adhesin.
Microbiological sciences.
70:1094-1104.
2008
|
|
| 2008
|
The effect of plasminogen activator inhibitor type 1 on apoptosis.
Thrombosis and Haemostasis.
100:1037-1040.
2008
|
|
| 2008
|
Phospholipase Cγ2 mediates RANKL-stimulated lymph node organogenesis and osteoclastogenesis.
Journal of Biological Chemistry.
283:29593-29601.
2008
|
|
| 2008
|
Calmodulin binding to cellular FLICE-like inhibitory protein modulates Fas-induced signalling.
Biochemical Journal.
412:459-468.
2008
|
|
| 2008
|
Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling.
Journal of Biological Chemistry.
283:15319-15327.
2008
|
|
| 2008
|
Calmodulin binding to the Fas-mediated death-inducing signaling complex in cholangiocarcinoma cells.
Journal of Cellular Biochemistry.
103:788-799.
2008
|
|
| 2007
|
Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma.
International Journal of Oncology.
31:843-850.
2007
|
|
| 2006
|
Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma.
International Journal of Oncology.
29:1319-1329.
2006
|
|
| 2006
|
Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.
Arteriosclerosis, Thrombosis, and Vascular Biology.
26:1777-1783.
2006
|
|
| 2006
|
Fas-mediated apoptosis in cholangiocarcinoma cells is enhanced by 3,3′-diindolylmethane through inhibition of AKT signaling and FLICE-like inhibitory protein.
American Journal of Pathology.
169:1833-1842.
2006
|
|
| 2004
|
Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1.
Journal of Cellular Biochemistry.
92:178-188.
2004
|
|
| 2002
|
Effect of fatty acid chain length and thioesterification on the augmentation of expression of plasminogen activator inhibitor-1.
Nutrition, Metabolism and Cardiovascular Diseases.
12:325-330.
2002
|
|
| 2002
|
The independence of signaling pathways mediating increased expression of plasminogen activator inhibitor type 1 in HepG2 cells exposed to free fatty acids or triglycerides.
International journal of experimental diabetes research.
3:109-118.
2002
|
|
| 2000
|
Identification and localization of a fatty acid response region in the human plasminogen activator inhibitor-1 gene.
Arteriosclerosis, Thrombosis, and Vascular Biology.
20:2696-2701.
2000
|
|
